Prehospital Point-of-Care Testing to Support Decision-Making in Alternative and Non-Conveyance Pathways: A Matched Parallel Cluster-Randomized Trial
The pre-POCT–Non-Conveyance Trial is a prospective, matched, cluster-randomised study investigating whether point-of-care blood testing can be integrated into routine prehospital assessment of clinically stable patients who are initially considered for hospital conveyance.
Ten ambulances in the Central Denmark Region participate in the study. Five ambulances are equipped with point-of-care testing devices, while five ambulances provide standard care without point-of-care testing. The ambulances were matched according to factors such as previous non-conveyance rates, activity level and geographical coverage before randomisation.
The overall aim is to determine whether rapid blood testing can be successfully incorporated into ambulance-based assessment and telemedical consultation before the final decision about hospital conveyance is made. The study also explores whether access to additional biochemical information may support safe decisions about whether selected patients need hospital transport or can remain at home.
A substantial proportion of patients transported by ambulance are discharged shortly after arriving at hospital without requiring advanced diagnostics or treatment. At the same time, decisions to leave patients at home must be made safely.
Point-of-care testing makes it possible to obtain selected blood test results directly at the scene. Providing this additional information during the prehospital assessment may help ambulance clinicians and physicians make more informed decisions about whether hospital conveyance is necessary.
The study includes 10 ambulances, which have been allocated to two groups:
5 intervention ambulances have access to point-of-care blood testing.
5 control ambulances continue standard prehospital care without access to point-of-care testing.
Patients are therefore allocated according to which participating ambulance attends them rather than being individually randomised.
In the intervention ambulances, blood tests can be performed directly at the scene using portable devices. The available analyses include electrolytes, renal function, glucose, C-reactive protein, haemoglobin and white blood cell count. Results can be discussed with an Emergency Medical Dispatch Centre (EMDC) physician as part of the overall clinical assessment before the final conveyance decision is made. patient care follow the same regional procedures in both groups.
The primary focus is whether prehospital point-of-care testing can be implemented reliably in everyday ambulance practice. This includes whether testing can be performed successfully, whether valid results can be obtained and documented, and whether the results are available before the final decision about hospital conveyance.
The study will also explore clinical outcomes including:
whether patients are conveyed to hospital or remain at home;
hospital admission following non-conveyance;
short hospital stays;
length of hospital stay;
intensive care admission; and
mortality.
These outcomes will help determine the feasibility and safety parameters needed to design a future definitive trial evaluating the clinical effectiveness of prehospital POCT-supported decision-making.